Albert David operations head resigns from Ghaziabad Plant

1 min read     Updated on 31 May 2026, 04:09 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Albert David Limited announced the resignation of Mr. Chandra Bhushan Thakur from the position of Head-Operations at its Ghaziabad Plant, effective from the close of business hours on May 29, 2026, due to personal reasons. The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and filed by Lalit Lohia, Company Secretary & Compliance Officer.

powered bylight_fuzz_icon
41684609

*this image is generated using AI for illustrative purposes only.

Albert David Limited has announced the resignation of Mr. Chandra Bhushan Thakur from the position of Head-Operations at its Ghaziabad Plant. The resignation is effective from the close of business hours on May 29, 2026. The company disclosed that the departure was due to personal reasons, marking a change in the plant's operational leadership.

The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted to BSE Limited and the National Stock Exchange of India Limited on May 30, 2026, by Lalit Lohia, the Company Secretary & Compliance Officer. The company acknowledged Mr. Thakur's contributions during his tenure.

Details of Resignation

The following table outlines the specific details regarding the change in senior managerial personnel as provided in the regulatory filing:

Particulars Details of Change
Reason for change Mr. Chandra Bhushan Thakur, Head-Operations, Ghaziabad Plant of the Company has tendered his resignation due to personal reasons.
Date of cessation Effective from closure of business hours on 29 May, 2026.
Brief Profile Not applicable
Disclosure of relationships Not applicable

The resignation was communicated internally via email from the HR Department, confirming the discontinuation of Mr. Thakur's retainership services. Albert David Limited has requested the exchanges to place the information on record.

Historical Stock Returns for Albert David

1 Day5 Days1 Month6 Months1 Year5 Years
-0.29%+0.09%-1.69%-10.91%-12.34%+53.02%

Who will be appointed as the successor to oversee operations at the Ghaziabad Plant?

How will this leadership transition impact the operational efficiency of the Ghaziabad Plant in the coming quarters?

Are there any strategic changes planned for the plant's management following this resignation?

Albert David FY26 Net Loss ₹149.47 Lakh; Dividend ₹5

5 min read     Updated on 15 May 2026, 08:13 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Albert David Limited reported a net loss of ₹149.47 lakh for the financial year ended March 31, 2026, reversing from a net profit of ₹1720.08 lakh in the previous year. Revenue from operations declined to ₹33359.81 lakh from ₹34576.80 lakh in FY25. The Board recommended a final dividend of ₹5.00 per share and appointed Mr. Amit Mahla as the new Chief Executive Officer.

powered bylight_fuzz_icon
40151685

*this image is generated using AI for illustrative purposes only.

Albert David Limited reported audited financial results for the quarter and financial year ended March 31, 2026, posting a net loss of ₹149.47 lakh for the full year. This represents a significant reversal from the net profit of ₹1720.08 lakh recorded in the previous fiscal year. Revenue from operations for FY26 stood at ₹33359.81 lakh, declining from ₹34576.80 lakh in FY25. Total income for FY26 was ₹34105.14 lakh against ₹37534.87 lakh in FY25, while total expenses were ₹34052.65 lakh compared to ₹35012.10 lakh previously. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on May 12, 2026.

Quarterly Performance

For the quarter ended March 31, 2026, Albert David reported a net loss of ₹2143.44 lakh, widening from a net loss of ₹1032.79 lakh in the corresponding quarter of the prior year. Revenue from operations for the quarter was ₹8586.34 lakh, compared to ₹7489.33 lakh in the same period last year. Total income for the quarter stood at ₹6102.50 lakh, while total expenses amounted to ₹8625.88 lakh. The loss before tax for the quarter was ₹2523.38 lakh, against a loss before tax of ₹1180.87 lakh in the year-ago quarter. The figures for the quarter ended March 31, 2026 represent the balancing figure between the audited full-year figures and the published unaudited year-to-date figures up to the third quarter.

Financial Performance Summary

The following table presents the key financial metrics for the full year and the latest quarter:

Metric: Q4 FY26 (₹ in Lacs) Q4 FY25 (₹ in Lacs) FY26 (₹ in Lacs) FY25 (₹ in Lacs)
Revenue from Operations: 8586.34 7489.33 33359.81 34576.80
Other Income: -2483.84 -511.44 745.33 2958.07
Total Income: 6102.50 6977.89 34105.14 37534.87
Total Expenses: 8625.88 8158.76 34052.65 35012.10
Profit/(Loss) Before Tax: -2523.38 -1180.87 52.49 2522.77
Net Profit/(Loss): -2143.44 -1032.79 -149.47 1720.08
Total Comprehensive Income: -1906.54 -1150.56 190.68 1606.58
Basic EPS (₹): -37.56 -18.10 -2.62 30.14
Diluted EPS (₹): -37.56 -18.10 -2.62 30.14

Balance Sheet Highlights

The statement of assets and liabilities as of March 31, 2026, showed total assets at ₹51913.28 lakh, a slight increase from ₹51141.56 lakh in the previous year. Total equity stood at ₹39153.63 lakh as against ₹39248.34 lakh in the prior year, comprising equity share capital of ₹570.72 lakh and other equity of ₹38582.91 lakh. Total current assets were ₹37440.29 lakh, while total current liabilities stood at ₹11543.02 lakh. Current borrowings rose to ₹2847.76 lakh from ₹1004.92 lakh in the previous year.

Parameter: 31.03.2026 (₹ in Lacs) 31.03.2025 (₹ in Lacs)
Total Assets: 51913.28 51141.56
Total Equity: 39153.63 39248.34
Total Non-Current Assets: 14472.99 15736.77
Total Current Assets: 37440.29 35404.79
Total Non-Current Liabilities: 1216.63 1475.22
Total Current Liabilities: 11543.02 10418.00
Current Borrowings: 2847.76 1004.92

Cash Flow Overview

The company's cash flow statement for the year ended March 31, 2026, showed net cash used in operating activities of ₹765.85 lakh, compared to ₹2843.58 lakh in the prior year. Net cash used in investing activities was ₹439.98 lakh, while net cash from financing activities stood at ₹1192.16 lakh. Closing cash and cash equivalents were ₹29.91 lakh, down from ₹41.73 lakh at the start of the year. The cash flow statement was prepared under the indirect method as per Ind AS-7.

Cash Flow Item: FY26 (₹ in Lacs) FY25 (₹ in Lacs)
Net Cash from Operating Activities: -765.85 -2843.58
Net Cash from Investing Activities: -439.98 2330.13
Net Cash from Financing Activities: 1192.16 11.03
Closing Cash and Cash Equivalents: 29.91 41.73

Audit Opinion and Dividend

M/s. L. B. Jha & Co., Chartered Accountants (Firm Registration No. 301088E/E300295), Statutory Auditors of the company, issued the Audit Report with an unmodified opinion on the financial results for the quarter and year ended March 31, 2026. The audit was signed by Partner Ranjan Singh (Membership No. 305423) at Kolkata on May 12, 2026. The Board of Directors recommended a final dividend of ₹5.00 per share of face value ₹10 each for the financial year ended March 31, 2026, subject to approval of shareholders at the 87th Annual General Meeting. The company has fixed July 30, 2026, as the record date for determining eligibility for the dividend and voting at the AGM. The register of members and share transfer books will remain closed from July 31, 2026, to August 6, 2026.

Board Decisions and Appointments

The Board appointed Mr. Amit Mahla as the Chief Executive Officer (CEO) of the company with effect from May 12, 2026, following the resignation of Mr. Umesh Manohar Kunte from the post of Managing Director & CEO. Mr. Mahla, aged approximately 52 years, brings over 28 years of experience in the pharmaceutical industry and has previously been associated with organisations including Cipla, Emcure, Glenmark, Alembic, Sun Pharma, and JB Pharma. He holds a degree in Science, a postgraduate degree in English Literature, and an Executive MBA from SIES, Mumbai. The board also re-appointed M/s. PricewaterhouseCoopers Services LLP as Internal Auditors and M/s. S. Gupta & Co. as Cost Auditors for the financial year 2026-27. The 87th AGM is scheduled to be held on August 6, 2026, via video conferencing.

Historical Stock Returns for Albert David

1 Day5 Days1 Month6 Months1 Year5 Years
-0.29%+0.09%-1.69%-10.91%-12.34%+53.02%

How might newly appointed CEO Amit Mahla's experience at major pharma firms like Cipla and Sun Pharma translate into a concrete turnaround strategy for Albert David's declining revenue and profitability?

Given the nearly threefold increase in current borrowings and negative operating cash flow, what refinancing or capital-raising options could Albert David pursue to strengthen its liquidity position in FY27?

Will the Board's decision to recommend a ₹5 dividend per share despite posting a net loss signal confidence in near-term recovery, or could it face shareholder pushback at the 87th AGM?

More News on Albert David

1 Year Returns:-12.34%